<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo>, including anticardiolipin antibodies (ACA), are strongly associated with <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> in patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>To date, reports about the binding specificities of ACA and their role(s) in causing and/or sustaining <z:mp ids='MP_0005048'>thrombosis</z:mp> in APS are conflicting and controversial </plain></SENT>
<SENT sid="2" pm="."><plain>The plasmas of patients with APS, usually containing a mixture of autoantibodies, vary in binding specificity for different <z:chebi fb="1" ids="16247">phospholipids</z:chebi>/cofactors and vary in in vitro <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity </plain></SENT>
<SENT sid="3" pm="."><plain>Although in vivo assays that allow assessment of the pathogenic procoagulant activity of patient autoantibodies have recently been developed, the complex nature of the mixed species prevented determination of the particular species responsible for in vivo <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We have generated two human IgG monoclonal ACA from an APS patient with <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Both bound to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> in the presence of 10% bovine serum, but not in its absence, and both were reactive against <z:chebi fb="0" ids="16337">phosphatidic acid</z:chebi>, but were nonreactive against purified human beta-2 glycoprotein 1, DNA, <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi>, or four other test antigens </plain></SENT>
<SENT sid="6" pm="."><plain>Both monoclonal autoantibodies lacked <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity and did not inhibit prothrombinase activity </plain></SENT>
<SENT sid="7" pm="."><plain>Remarkably, one of the monoclonal antibodies has thrombogenic properties when tested in an in vivo mouse model </plain></SENT>
<SENT sid="8" pm="."><plain>This finding provides the first direct evidence that a particular <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> specificity may contribute to in vivo <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>